my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Anemia is a major clinical symptom of a wide variety of pathological conditions a common related to reduced erythropoiesis. Whereas erythropoietin treatment showed an improvement in the patients’ condition, it revealed increased risks of thromboembolic and cardiovascular events. Herein we describe stimulation of erythropoiesis by the multifunctional 1-(butyryloxy)ethyl-5-amino-4-oxopentanoate, (AlaAcBu), a 5-aminolevulinic-acid (ALA) derivative, which undergoes metabolic hydrolysis yielding two erythroid differentiation inducers, ALA and butyric acid (BA), each acting through a different mechanism. ALA, the first precursor in the heme biosynthesis, accelerates heme synthesis and BA, a histone deacetylase inhibitor (HDACI) that activates the transcription of globin mRNA. Our results show that the AlaAcBu mutual prodrug is a potent chemical differentiation inducer of K562 human erythroleukemia cells manifested by augmentation of heme and globin synthesis and assembly of hemoglobin. Exposure of K-562 cells to AlaAcBu resulted in an increase in heme synthesis and globin expression. Stimulation of the heme pathway was evident by the over-expression of porphobilinogen deaminase (PBGD) and ferrochelatase. AlaAcBu promoted cellular erythroid differentiation depicted by the expression of the marker glycophorin A and cellular maturation characterized by cytoplasm hemoglobinization, polar arrangement of mitochondria and a developed central vacuolar system preceding nuclear extrusion. The ability of AlaAcBu to promote differentiation along the erythroid lineage and to dramatically induce hemoglobin synthesis presented in this report.
Graphical abstract
| Authors: | G. Berkovitch-Luria, S. Yakobovitch, M. Weitman, A. Nudelman, G. Rozic, A. Rephaeli, Z. Malik | |
| Journal: | European Journal of Pharmaceutical Science | |
| Year: | 2012 | |
| DOI: | 10.1016/j.ejps.2012.05.017 | |
| Publication date: | 02-07-2012 |
Watchlist
This is where you can add this publication to your personal favourites.
Additional Information
Production of advanced biofuels in engineered E. coli
Publication date: Available online 6 May 2013 Source:Current Opinion in Chemical Biology Author(s): Miao Wen , Brooks B Bond-Watts , Michelle CY Chang Commercial fermentation processes have long taken advantage of the synthetic power of living systems to rapidly and efficiently tra ... more
Protein conjugation with genetically encoded unnatural amino acids
Publication date: Available online 9 May 2013 Source:Current Opinion in Chemical Biology Author(s): Chan Hyuk Kim , Jun Y Axup , Peter G Schultz The site-specific incorporation of unnatural amino acids with orthogonal chemical reactivity into proteins enables the synthesis of struc ... more
Chemistry and combustion of fit-for-purpose biofuels
Publication date: Available online 8 May 2013 Source:Current Opinion in Chemical Biology Author(s): David A Rothamer , Timothy J Donohue From the inception of internal combustion engines, biologically derived fuels (biofuels) have played a role. Nicolaus Otto ran a predecessor to to ... more
Novel study reports marijuana users have better blood sugar control
Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes ... more
More severe concussion symptoms lead to longer recovery time
Most children who suffer from sports-related concussions recover within a few days. However, in a small number of children, symptoms can last for a month or more. Although there have been numerous theories as to what might predict a longer recovery time, there is no definitive answer as to ... more
For breast cancer screening, one size doesn’t fit all
Although mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, it has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term ef ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
